| Page 4 | Kisaco Research
 

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics
  • Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
  • Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
  • How to maximise the use of biobanks in biomarker discovery.

Author:

Sanj Singh

CEO
Temple Therapeutics

Sanj Singh

CEO
Temple Therapeutics
 

Cindy Rahman

President & CEO
March of Dimes

Cindy Rahman

President & CEO
March of Dimes

Cindy Rahman

President & CEO
March of Dimes
Enterprise AI - Sample Attendee List
 

Sheeva Talebian

Reproductive Endocrinologist
CCRM New York

Sheeva Talebian

Reproductive Endocrinologist
CCRM New York

Sheeva Talebian

Reproductive Endocrinologist
CCRM New York
  • Sharing the role of technology and partnerships in the design & recruitment of studies.
  • Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
  • Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.